Alteration of TP53 (e.g., [66]) and another signaling (e.g., [67]) pathways in the prostate cancer were analyzed by several other groups before, but this is the first time after our knowledge that the analysis goes beyond expression regulation to explore also the expression coordination. The gene discussed is TP53; the disease is prostate carcinoma.